Cargando…
Initial mycophenolate dose in tacrolimus treated renal transplant recipients, a cohort study comparing leukopaenia, rejection and long-term graft function
The evidence supporting an initial mycophenolate mofetil (MMF) dose of 2 g daily in tacrolimus-treated renal transplant recipients is limited. In a non-contemporaneous single-centre cohort study we compared the incidence of leukopaenia, rejection and graft dysfunction in patients initiated on MMF 1....
Autores principales: | Dave, Vatsa, Polkinghorne, Kevan R., Leong, Khai Gene, Kanellis, John, Mulley, William R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653942/ https://www.ncbi.nlm.nih.gov/pubmed/33168923 http://dx.doi.org/10.1038/s41598-020-76379-6 |
Ejemplares similares
-
Results from an International Survey of Donor and Recipient Eligibility for Solid Organ Pancreas Transplantation
por: Ling, Jonathan E.H., et al.
Publicado: (2021) -
Tacrolimus/methotrexate vs tacrolimus/reduced-dose methotrexate/mycophenolate for graft-versus-host disease prevention
por: Hamilton, Betty K., et al.
Publicado: (2023) -
Risk indices predicting graft use, graft and patient survival in solid pancreas transplantation: a systematic review
por: Ling, Jonathan E. H., et al.
Publicado: (2021) -
Role of tacrolimus combination therapy with mycophenolate mofetil in the prevention of organ rejection in kidney transplant patients
por: Dalal, P, et al.
Publicado: (2010) -
Mycophenolic Acid Trough Concentration and Dose Are Associated with Hematologic Abnormalities but Not Rejection in Kidney Transplant Recipients
por: Jung, Hee-Yeon, et al.
Publicado: (2020)